2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 7.456 | 58.435 | 57.315 | 61.761 | 61.199 | 65.517 | 72.757 | 74.612 | 77.460 |
Total Income - EUR | - | 7.802 | 58.443 | 58.026 | 62.943 | 62.191 | 71.265 | 73.339 | 75.607 | 79.387 |
Total Expenses - EUR | - | 14.052 | 52.241 | 57.279 | 60.887 | 61.466 | 72.983 | 69.555 | 73.762 | 74.710 |
Gross Profit/Loss - EUR | - | -6.250 | 6.202 | 747 | 2.056 | 724 | -1.717 | 3.783 | 1.845 | 4.677 |
Net Profit/Loss - EUR | - | -6.484 | 5.033 | 166 | 1.426 | 110 | -2.333 | 3.163 | 1.203 | 4.042 |
Employees | - | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Rafael Pharm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 84 | 0 | 0 | 612 | 486 | 364 | 246 | 134 | 1.923 |
Current Assets | - | 8.715 | 10.101 | 11.502 | 15.172 | 13.964 | 15.996 | 22.211 | 20.146 | 20.844 |
Inventories | - | 8.120 | 7.748 | 5.585 | 6.419 | 5.994 | 7.622 | 6.723 | 8.829 | 11.157 |
Receivables | - | 578 | 1.503 | 5.704 | 8.423 | 7.043 | 7.819 | 11.251 | 8.413 | 8.032 |
Cash | - | 17 | 850 | 213 | 330 | 927 | 555 | 4.237 | 2.903 | 1.655 |
Shareholders Funds | - | -6.439 | -1.340 | -1.151 | 296 | 400 | -1.940 | 1.265 | 2.473 | 6.507 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 15.238 | 11.441 | 12.653 | 15.487 | 14.050 | 18.301 | 21.192 | 17.807 | 16.260 |
Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Rafael Pharm Srl